๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Stomach Neuroendocrine Neoplasm

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours NCT06155318n/a1 site๐Ÿ“ Milan IRCCS San Raffaele ยท Tests: 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: [18F]FAPI-74, [18F]FDG Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites๐Ÿ“ Anderlecht๐Ÿ“ Ghent๐Ÿ“ Wilrijk European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Stereotactic body radiotherapy, Palliative RT Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients NCT05701241Phase 419 sites๐Ÿ“ Brasschaat๐Ÿ“ Rumst๐Ÿ“ Ghent University Hospital, Antwerp ยท Tests: Somatostatin analog Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites๐Ÿ“ Greenwood Village๐Ÿ“ Manchester๐Ÿ“ Daytona Beach University of Nebraska YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. NCT06337760n/a1 site๐Ÿ“ Milan European Institute of Oncology EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites๐Ÿ“ Birmingham๐Ÿ“ Chandler๐Ÿ“ Hot Springs Guardant Health, Inc. ยท Tests: Guardant Reveal Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors NCT06441331Phase 17 sites๐Ÿ“ San Francisco๐Ÿ“ Cincinnati๐Ÿ“ Philadelphia ITM Solucin GmbH ยท Tests: Lutetium Lu 177-Edotreotide, Amino Acid Solution A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytrudaยฎ) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) NCT04198766Phase 1, Phase 242 sites๐Ÿ“ Duarte๐Ÿ“ Glendale๐Ÿ“ Los Angeles Inhibrx Biosciences, Inc ยท Tests: INBRX-106 - Hexavalent OX40 agonist antibody, pembrolizumab 200 mg, pembrolizumab 400 mg, Carboplatin AUC-5, Carboplatiโ€ฆ Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis NCT06881511NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: No intervention (Control Group), Oral betaine hydrochloride (2 capsules, 3 times daily) A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors NCT07317505Phase 13 sites๐Ÿ“ Huntersville๐Ÿ“ Dallas๐Ÿ“ Fairfax Conjupro Biotherapeutics, Inc. ยท Tests: JMT108 Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728Phase 23 sites๐Ÿ“ Abbotsford๐Ÿ“ Northcote๐Ÿ“ Leederville Psyence Australia Pty Ltd ยท Tests: Psilocybin therapy Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132Phase 114 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Iowa City RayzeBio, Inc. ยท Tests: RYZ401 Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors NCT04090034n/a2 sites๐Ÿ“ Dallas๐Ÿ“ Dallas Methodist Health System ยท Tests: Peptide Receptor Radionuclide Therapy Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs NCT06356467n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Protocol ITANET - Registry NCT04282083n/a37 sites๐Ÿ“ Rozzano๐Ÿ“ Peschiera del Garda๐Ÿ“ Ancona Italian Association Neuroendocrine Tumors Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. NCT07150546Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Stereotactic Body Radiation Therapy, Lutetium Lu 177 Dotatate, Computed Tomography, Magnetic Resonance Imaging, Galliumโ€ฆ Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN NCT06735560NA2 sites๐Ÿ“ Nantes๐Ÿ“ Paris Nantes University Hospital ยท Tests: 89Zr-TLX250 PET/CT Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) NCT04893785Phase 21 site๐Ÿ“ Naples National Cancer Institute, Naples ยท Tests: Cabozantinib and Temozolomide Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) NCT05196087n/a1 site๐Ÿ“ Toronto University Health Network, Toronto
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy